Zai Lab Limited American Depositary Shares (ZLAB) is a publicly traded Healthcare sector company. As of May 21, 2026, ZLAB trades at $18.44 with a market cap of $2.12B and a P/E ratio of -108.98. ZLAB moved +2.29% today. Year to date, ZLAB is +3.98%; over the trailing twelve months it is -42.35%. Its 52-week range spans $15.96 to $44.34. Analyst consensus is strong buy with an average price target of $34.27. Rallies surfaces ZLAB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
ZLAB financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. ZLAB recently traded at $18.44. Market cap is $2.12B. P/E ratio is -108.98. Revenue is $453.28M.
| Metric | Value |
|---|---|
| Price | $18.44 |
| Market Cap | $2.12B |
| P/E Ratio | -108.98 |
| EPS | $-0.17 |
| Dividend Yield | 0.00% |
| 52-Week High | $44.34 |
| 52-Week Low | $15.96 |
| Volume | 151 |
| Avg Volume | 0 |
| Revenue (TTM) | $453.28M |
| Net Income | $-178.12M |
| Gross Margin | 58.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2023 | $266.72M | $-334.62M | $-0.35 |
| 2022 | $215.04M | $-443.29M | $-0.46 |
| 2021 | $144.31M | $-704.47M | $0.00 |
| 2020 | $48.96M | $-268.90M | $0.00 |
4 analysts cover ZLAB: 0 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $34.27.